1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. AURINIA PHARMACEUTICALS INC
Aurinia Pharmaceuticals Inc XNAS: AUPH

Aurinia Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for ...

Read More
12.00 0.32 (2.74%)
Near 52W High of $12.53
2.3M
XNAS Volume

XNAS 03 Sep, 2025 4:04 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
77.8 / 100
Valuation Score
Mid Valuation
39.0 / 100
Momentum Score
Technically Moderately Bullish
63.4 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
12
1Yr Price target downside is -2%
7 analysts

27

S

3

W

0

O

3

T

SWOT Analysis

Aurinia Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..